IHS Chemical Week

Regions :: North America :: U.S.

Lonza Expands, Revamps Former Cambrex Site at Hopkinton, MA (update)

8:15 AM MDT | April 23, 2009 | Alex Scott

Lonza, one of the world’s most successful contract fine chemical companies, says it has completed the build out of a new mid-scale volume biologic drugs manufacturing facility at Hopkinton, MA. In parallel, Lonza says it has also revamped the entire Hopkinton site-formerly owned by Cambrex-to enhance infrastructure reliability including electricity and waste streams, and increase operational efficiency while meeting cGMP requirements. The new facility, a 2,000-liter microbial fermentation plant, is complemented by a highly flexible purification area capable...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa